At the turn of the century, some studies suggested that low IGF-I levels were associated with increased ischemic heart disease [30] and that IGF-1 protects against endothelial dysfunction, atherosclerotic plaque development, metabolic syndrome, clinical instability, and ischemic myocardial damage [31]. The gene discussed is IGF1; the disease is metabolic syndrome.